The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (304.45) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -20810.9%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 20810.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.6% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (582.63) - (208.44) | (304.45) |
| Upside | -39734.7% - -14279.4% | -20810.9% |